CD19 Directed Cytolytic Antibodies
DBCAT005691Pharmacologic class
A DrugBank category of 1 drug. 1 of them is approved.
- Part of
- Antibodies
- Drugs
What you can answer from here — as of November 29, 2022
Which targets do CD19 Directed Cytolytic Antibodies share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account